Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S9LK
|
|||
Former ID |
DIB003593
|
|||
Drug Name |
GSK-2584786A
|
|||
Synonyms |
Influenza vaccine (adjuvanted, quadrivalent), GlaxoSmithKline Biologicals; Influenza vaccine (quadrivalent, intramuscular), GlaxoSmithKline Biologicals
Click to Show/Hide
|
|||
Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 2 | [1] | |
Company |
GlaxoSmithKline Biologicals
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01195779) Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.